Riamol Infusion Paracetamol Infusion IP, 100 ml

₹ 25/Piece

Pack Size100 ml
Strength1000mg/100ml
Pack TypeBox
Drug CompositionParacetamol 1000mg
BrandRiamol
TreatmentHelps In Relieving Moderate Pain And Reducing Fever
AvailabilityIn Stock
Established in 2021 at Ahmedabad, 382330(Gujarat,India).We "Urvidhya Medicare Enterprise" Limited Company Based on Ranitidine Hydrochloride Injection IP, Bromol Paracetamol Injection, Frusemide Injection IP, Etofylline And Theophylline Injection, Glycopyrrolate Injection USP, Cefoperazone Sulbactam Injection, Pheniramine Maleate Injection Ip Avil and many more such products.

Exports To: United States Of America | Nepal | Bangladesh | Somalia | Sudan

Find products similar to Riamol Infusion Paracetamol Infusion IP, 100 Ml

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromAhmedabad
ShippingAs per delivery location

Product Image

Riamol Infusion Paracetamol Infusion IP, 100 ml image 1Riamol Infusion Paracetamol Infusion IP, 100 ml image 2

About the Company

GST Registration Date
Jan 2022
Legal Status of Firm
Proprietorship
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
Upto 10 People
Annual Turnover
0 - 40 L
IndiaMART Member Since
Jan 2022
GST
24**********1ZG
Import Export Code (IEC)
*******12P
Exports to
United States Of America | Nepal | Bangladesh | Somalia | Sudan

Established in the year of 2021 , we “Urvidhya Medicare Enterprise " are a Wholesaler Trader, Distributor and Exporter of an extensive array Pharmaceutical Medicines, Pharmaceutical Tablets, Pharmaceutical Injection etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.

For our accomplishment story, we are grateful to our Mr. Urvashiben Dipakkumar Shukla (CEO), whose continual backing and directions have been useful to us for attaining exponential development in the current market.